Shopping Cart 0
Cart Subtotal
AED 0

CardioGenics Inc - Product Pipeline Analysis, 2019 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 2753

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 5505

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 8258

Details

Summary

CardioGenics Inc (CardioGenics), a subsidiary of CardioGenics Holdings Inc is a medical device company that manufactures sensitive diagnostic test products to the in-vitro diagnostics market. The company's products include QL care analyzer, immunoassay tests, and paramagnetic beads, among others. Its QL care analyzer is a portable and automated point of care immune analyzer. CardioGenics provides immunoassay tests such as heart failure genomics risk test, heart failure risk stratification test, plasminogen activator inhibitor type-1 test, and troponin I test. The company's immunoassay tests are used to detect cardiac markers. It also develops a novel proprietary and patent-protected method to control the delivery of compounds to a chemical reaction automating the trigger. CardioGenics is headquartered in Mississauga, Ontario, Canada.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company CardioGenics Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

CardioGenics Inc Company Overview

CardioGenics Inc Company Snapshot

CardioGenics Inc Pipeline Products and Ongoing Clinical Trials Overview

CardioGenics Inc-Pipeline Analysis Overview

CardioGenics Inc-Key Facts

CardioGenics Inc-Major Products and Services

CardioGenics Inc Pipeline Products by Development Stage

CardioGenics Inc Pipeline Products Overview

Heart Failure Genomics Risk Test

Heart Failure Genomics Risk Test Product Overview

Heart Failure Risk Stratification Test

Heart Failure Risk Stratification Test Product Overview

Plasminogen Activator Inhibitor Type-1 Test

Plasminogen Activator Inhibitor Type-1 Test Product Overview

QL Care Analyzer

QL Care Analyzer Product Overview

Troponin-I Test

Troponin-I Test Product Overview

CardioGenics Inc-Key Competitors

CardioGenics Inc-Key Employees

CardioGenics Inc-Locations And Subsidiaries

Head Office

Recent Developments

CardioGenics Inc, Recent Developments

Aug 25, 2015: CardioGenics Enters Into Manufacturing Agreement With Ontario-Based Plasticap

Feb 17, 2015: USPTO Issues Notice of Allowance in Connection With CardioGenics' Self-Metering Cartridge Patent Application

Aug 21, 2013: CardioGenics Announces Commencement of Beta-Site Testing

Jun 05, 2013: CardioGenics Gets IRB Approval For Beta-Site Testing

Apr 03, 2012: CardioGenics Announces Agreements with INO to Manufacture QL Care Analyzers

Dec 20, 2011: CardioGenics Announces Submission to IRB for Beta Site Protocol Approval For QL Care Analyzer

Dec 20, 2011: CardioGenics Announces Submission to IRB for Beta Site Protocol Approval For Troponin-I cardiovascular test

Jun 29, 2011: CardioGenics Receives US Patent For QL Care Analyzer Core Technology

Feb 22, 2011: CardioGenics Receives Canadian Patent For QL Care Analyzer Core Technology

Feb 03, 2011: CardioGenics To File For 510(k) Clearance With FDA By Fourth Quarter Of 2011 For QL Care Analyzer

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

CardioGenics Inc Pipeline Products by Equipment Type

CardioGenics Inc Pipeline Products by Development Stage


List Of Table

List of Tables

CardioGenics Inc Pipeline Products and Ongoing Clinical Trials Overview

CardioGenics Inc Pipeline Products by Equipment Type

CardioGenics Inc Pipeline Products by Indication

CardioGenics Inc, Key Facts

CardioGenics Inc, Major Products and Services

CardioGenics Inc Number of Pipeline Products by Development Stage

CardioGenics Inc Pipeline Products Summary by Development Stage

Heart Failure Genomics Risk Test-Product Status

Heart Failure Genomics Risk Test-Product Description

Heart Failure Risk Stratification Test-Product Status

Heart Failure Risk Stratification Test-Product Description

Plasminogen Activator Inhibitor Type-1 Test-Product Status

Plasminogen Activator Inhibitor Type-1 Test-Product Description

QL Care Analyzer-Product Status

QL Care Analyzer-Product Description

Troponin-I Test-Product Status

Troponin-I Test-Product Description

CardioGenics Inc, Key Employees

Glossary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

CardioGenics Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Somagen Diagnostics Inc

Biocore Systems Inc.

AMG Medical Inc

Company Profile

Company Profile Title

Summary

CardioGenics Inc (CardioGenics), a subsidiary of CardioGenics Holdings Inc is a medical device company that manufactures sensitive diagnostic test products to the in-vitro diagnostics market. The company's products include QL care analyzer, immunoassay tests, and paramagnetic beads, among others. Its QL care analyzer is a portable and automated point of care immune analyzer. CardioGenics provides immunoassay tests such as heart failure genomics risk test, heart failure risk stratification test, plasminogen activator inhibitor type-1 test, and troponin I test. The company's immunoassay tests are used to detect cardiac markers. It also develops a novel proprietary and patent-protected method to control the delivery of compounds to a chemical reaction automating the trigger. CardioGenics is headquartered in Mississauga, Ontario, Canada.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company CardioGenics Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

CardioGenics Inc Company Overview

CardioGenics Inc Company Snapshot

CardioGenics Inc Pipeline Products and Ongoing Clinical Trials Overview

CardioGenics Inc-Pipeline Analysis Overview

CardioGenics Inc-Key Facts

CardioGenics Inc-Major Products and Services

CardioGenics Inc Pipeline Products by Development Stage

CardioGenics Inc Pipeline Products Overview

Heart Failure Genomics Risk Test

Heart Failure Genomics Risk Test Product Overview

Heart Failure Risk Stratification Test

Heart Failure Risk Stratification Test Product Overview

Plasminogen Activator Inhibitor Type-1 Test

Plasminogen Activator Inhibitor Type-1 Test Product Overview

QL Care Analyzer

QL Care Analyzer Product Overview

Troponin-I Test

Troponin-I Test Product Overview

CardioGenics Inc-Key Competitors

CardioGenics Inc-Key Employees

CardioGenics Inc-Locations And Subsidiaries

Head Office

Recent Developments

CardioGenics Inc, Recent Developments

Aug 25, 2015: CardioGenics Enters Into Manufacturing Agreement With Ontario-Based Plasticap

Feb 17, 2015: USPTO Issues Notice of Allowance in Connection With CardioGenics' Self-Metering Cartridge Patent Application

Aug 21, 2013: CardioGenics Announces Commencement of Beta-Site Testing

Jun 05, 2013: CardioGenics Gets IRB Approval For Beta-Site Testing

Apr 03, 2012: CardioGenics Announces Agreements with INO to Manufacture QL Care Analyzers

Dec 20, 2011: CardioGenics Announces Submission to IRB for Beta Site Protocol Approval For QL Care Analyzer

Dec 20, 2011: CardioGenics Announces Submission to IRB for Beta Site Protocol Approval For Troponin-I cardiovascular test

Jun 29, 2011: CardioGenics Receives US Patent For QL Care Analyzer Core Technology

Feb 22, 2011: CardioGenics Receives Canadian Patent For QL Care Analyzer Core Technology

Feb 03, 2011: CardioGenics To File For 510(k) Clearance With FDA By Fourth Quarter Of 2011 For QL Care Analyzer

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

CardioGenics Inc Pipeline Products by Equipment Type

CardioGenics Inc Pipeline Products by Development Stage


List Of Table

List of Tables

CardioGenics Inc Pipeline Products and Ongoing Clinical Trials Overview

CardioGenics Inc Pipeline Products by Equipment Type

CardioGenics Inc Pipeline Products by Indication

CardioGenics Inc, Key Facts

CardioGenics Inc, Major Products and Services

CardioGenics Inc Number of Pipeline Products by Development Stage

CardioGenics Inc Pipeline Products Summary by Development Stage

Heart Failure Genomics Risk Test-Product Status

Heart Failure Genomics Risk Test-Product Description

Heart Failure Risk Stratification Test-Product Status

Heart Failure Risk Stratification Test-Product Description

Plasminogen Activator Inhibitor Type-1 Test-Product Status

Plasminogen Activator Inhibitor Type-1 Test-Product Description

QL Care Analyzer-Product Status

QL Care Analyzer-Product Description

Troponin-I Test-Product Status

Troponin-I Test-Product Description

CardioGenics Inc, Key Employees

Glossary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

CardioGenics Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Somagen Diagnostics Inc

Biocore Systems Inc.

AMG Medical Inc